Is Pfizer Inc. (PFE) The Best Healthcare Dividend Stock to Invest in?

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best healthcare dividend stocks to invest in.

The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry. The rise of telehealth, virtual consultations, and technological advancements has reshaped the way healthcare services are delivered.

Over the past two decades, the healthcare sector has expanded considerably in relation to the broader economy, as reflected in its growing share of gross domestic product (GDP). According to a report by CNBC, in 2003, healthcare spending made up 15.7% of US GDP, increasing by approximately 1.7 percentage points over the next decade to reach 17.4% in 2013. Today, it is estimated at around 18.4% of GDP, and projections from the Centers for Medicare & Medicaid Services suggest it could rise to 20% by 2030. This steady increase is driven by several factors, including rising demand for healthcare services, advancements in medical technology, and escalating costs. The aging population, particularly as baby boomers retire, has significantly increased the need for medical care, while longer life expectancies have resulted in prolonged healthcare utilization. In addition, the prevalence of chronic conditions such as diabetes, cardiovascular diseases, and obesity has contributed to rising costs. The latest breakthroughs in diagnostics, treatments, and pharmaceuticals—though beneficial—often come with higher expenses, further fueling the sector’s expansion.

The healthcare industry’s share of the overall economy has expanded, with healthcare companies experiencing faster revenue growth than the broader market in the past five years. During this period, healthcare sector revenues have increased by nearly 61%, compared to just over 38% growth for the broader market as a whole, as reported by CNBC. However, despite this strong revenue performance, the healthcare sector has lagged behind the broader market index, which has been driven by the rapid expansion of the technology sector.

The healthcare sector faced a turbulent year in 2024. During the first half, investors gravitated toward industries such as technology and communication services, particularly those linked to the growing influence of AI, leaving healthcare stocks trailing behind. However, as the market rally broadened in the second half of the year, healthcare stocks saw some recovery, though certain segments continued to struggle with lingering supply-and-demand imbalances from the pandemic. Beyond these challenges, fundamental issues and policy uncertainties created additional obstacles for parts of the sector. While some regulatory pressures may ease with the incoming administration, others—such as drug pricing concerns—are expected to remain a persistent issue.

On a positive note, innovation remained robust throughout the year. Biotech companies delivered a series of encouraging clinical updates while growing enthusiasm for new treatments targeting obesity and diabetes contributed to an increase in pharmaceutical firms’ market valuations. A Fidelity report suggested that the healthcare sector is well-positioned for growth in 2025. The industry benefits from strengthening business fundamentals, such as rising cash flows, and encompasses a diverse range of segments that offer a blend of defensive stability and growth potential, making it appealing across different market conditions.

The healthcare sector is also attracting attention due to its rising dividend payouts. In the third quarter of 2024, total dividends distributed by the global healthcare industry reached $25.7 billion, up from $18.7 billion in Q3 2018, reflecting steady growth in shareholder returns, according to a report by Janus Henderson. Given this, we will take a look at some of the best dividend stocks in the healthcare sector.

Our Methodology

For this list, we scanned Insider Monkey’s database of Q4 2024 and picked healthcare dividend companies. From that list, we chose healthcare stocks with a strong track record of paying dividends to shareholders, which makes them resilient in the current environment. The stocks are ranked in ascending order of the hedge fund investors owning stakes in them, according to Insider Monkey’s database of Q4 2024.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Is Pfizer Inc. (PFE) The Best Healthcare Dividend Stock to Invest in?

A medical technician wearing protective gloves and a mask mixing a biopharmaceutical solution.

Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 92

Pfizer Inc. (NYSE:PFE) is a New York-based pharmaceutical and biotech company that specializes in a wide range of related services and products. The company reported a 12% operational revenue increase from its non-COVID products over the past year, showcasing its commitment to strategic execution. It successfully met its $4 billion net cost savings target through an ongoing cost realignment initiative and has now raised its goal to approximately $4.5 billion by the end of 2025. In addition, under its Manufacturing Optimization Program, Pfizer aims to achieve $1.5 billion in net cost savings by 2027, with the first benefits expected in the latter half of 2025. The company remains confident in its ability to restore operating margins to pre-pandemic levels in the coming years.

Pfizer Inc. (NYSE:PFE) has also focused on strengthening its presence in oncology, which was highlighted by a significant $43 billion acquisition of Seagen to enhance its cancer treatment portfolio. The company expects substantial growth in this segment over the next five years, with plans to double its patient base by 2030 and introduce at least three blockbuster drugs, each projected to generate over $1 billion in annual sales. Its progress in oncology is already evident, with revenue from this segment rising 25% in 2024.

Pfizer Inc. (NYSE:PFE), one of the best dividend stocks, offers a quarterly dividend of $0.43 per share, having raised it by 2.4% in December 2024. The stock offers an attractive dividend yield of 6.58%, as of March 20. It has been growing its payouts for 15 consecutive years.

Overall, PFE ranks 5th on our list of best healthcare dividend stocks to invest in. While we acknowledge the potential of PFE as an investment, our conviction lies in the belief that some deeply undervalued dividend stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for a deeply undervalued dividend stock that is more promising than PFE but that trades at 10 times its earnings and grows its earnings at double digit rates annually, check out our report about the dirt cheap dividend stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires

Disclosure: None. This article is originally published at Insider Monkey.